These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 3817367)

  • 1. [Use of amrinone in refractory cardiac insufficiency: clinical and hemodynamic evaluation].
    Massari FM; De Martini M; Foresti A; Valentini R; Bertoni T; Lotto A
    G Ital Cardiol; 1986 Oct; 16(10):845-54. PubMed ID: 3817367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hemodynamic and clinical effects and treatment tolerance with low-dose iv amrinone in patients with refractory heart failure: a multicenter study. The Group for Research on Amrinone in the Treatment of Refractory Heart Failure].
    Dei Cas L; Metra M; Nodari S; Raddino R; Visioli O
    Cardiologia; 1991 May; 36(5):363-71. PubMed ID: 1756541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized comparison of intravenous amrinone versus dobutamine in older patients with decompensated congestive heart failure.
    Rich MW; Woods WL; Davila-Roman VG; Morello PJ; Kurz H; Barbarash R; Spinner L; Sperry J; Beckham V; Coulter L
    J Am Geriatr Soc; 1995 Mar; 43(3):271-4. PubMed ID: 7884117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of amrinone in acute severe cardiac failure.
    Heuer H; Frenking B; Gülker H
    Arzneimittelforschung; 1988 Apr; 38(4):567-70. PubMed ID: 3401270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The hemodynamic profile of the response to amrinone treatment in severe heart failure].
    Domínguez de Rozas J; García Picart J; Guindo Soldevila J; Altimiras Ruiz J; Binia Mizrahi M; Pastor Ramón E; Bayés de Luna A
    Rev Esp Cardiol; 1991 Apr; 44(4):226-32. PubMed ID: 2068366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Efficacy and safety of amrinone in the treatment of heart insufficiency in intensive care].
    Costa P; Agrò C; Gulotta G; Papa G; Piazza F; Ronga F; Sparacia B; Sansone A
    Minerva Anestesiol; 1992 May; 58(5):301-10. PubMed ID: 1635643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hemodynamic effects of amrinone, phosphodiesterase inhibitor, early after coronary artery bypass grafting].
    Shibata T; Suehiro S; Minamimura H; Sasaki Y; Ishikawa T; Hattori K; Kinoshita H
    Nihon Kyobu Geka Gakkai Zasshi; 1996 Nov; 44(11):2027-31. PubMed ID: 8958718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amrinone in severe congestive heart failure: another look at an intriguing new cardioactive drug.
    Hermiller JB; Leithe ME; Magorien RD; Unverferth DV; Leier CV
    J Pharmacol Exp Ther; 1984 Feb; 228(2):319-26. PubMed ID: 6694112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Severe cardiac decompensation: value in the early hours of a combination of amrinone and dobutamine].
    Fosse JP; Pourriat JL; Hoang P; Fournier JL; Aïtkaciali F; Cupa M
    Cah Anesthesiol; 1989 Dec; 37(8):581-5. PubMed ID: 2637778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of intravenous amrinone and dobutamine in congestive heart failure due to idiopathic dilated cardiomyopathy.
    Marcus RH; Raw K; Patel J; Mitha A; Sareli P
    Am J Cardiol; 1990 Nov; 66(15):1107-12. PubMed ID: 2220638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of bolus milrinone on hemodynamic variables and pulmonary vascular resistance in patients with severe left ventricular dysfunction: a rapid test for reversibility of pulmonary hypertension.
    Givertz MM; Hare JM; Loh E; Gauthier DF; Colucci WS
    J Am Coll Cardiol; 1996 Dec; 28(7):1775-80. PubMed ID: 8962566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hemodynamic effects of intravenous clonidine in patients with acute myocardial infarction].
    Foresti A; Massari FM; Moglia F; Lotto A
    G Ital Cardiol; 1982; 12(11):767-74. PubMed ID: 6763571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of amrinone administered orally and by injection in heart failure].
    Bounhoure JP; Massabuau P; Puel J; Miquel JP; Calazel J
    Ann Med Interne (Paris); 1985; 136(3):251-5. PubMed ID: 3896092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery.
    Schroth M; Plank C; Meissner U; Eberle KP; Weyand M; Cesnjevar R; Dötsch J; Rascher W
    Pediatrics; 2006 Jul; 118(1):e76-84. PubMed ID: 16751617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemodynamic and clinical limitations of long-term inotropic therapy with amrinone in patients with severe chronic heart failure.
    Packer M; Medina N; Yushak M
    Circulation; 1984 Dec; 70(6):1038-47. PubMed ID: 6388899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Amrinone in acute and long-term therapy].
    Klepzig M; Kleinhans E; Büll U; Strauer BE
    Z Kardiol; 1985 Feb; 74(2):85-90. PubMed ID: 3922139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Canadian multicentre study of a 48 h infusion of milrinone in patients with severe heart failure.
    Pflugfelder PW; O'Neill BJ; Ogilvie RI; Beanlands DS; Tanser PH; Tihal H; Mizgala HF; Fitchett DH; Kostuk WJ
    Can J Cardiol; 1991; 7(1):5-10. PubMed ID: 2025794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Acute changes in the hemodynamic profile and circulating levels of atrial natriuretic peptide induced by dobutamine in severe heart failure].
    La Vecchia L; Bottero M; Centofante P; Bedogni F; Ometto R; Cera A; Fortunato A
    G Ital Cardiol; 1996 Aug; 26(8):863-74. PubMed ID: 9005168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemodynamic and neurohumoral effects of long-term prostaglandin E1 infusions in outpatients with severe congestive heart failure.
    Hülsmann M; Stanek B; Frey B; Berger R; Rödler S; Siegel A; Hartter E; Schuller M; Ogris E; Pacher R
    J Heart Lung Transplant; 1997 May; 16(5):556-62. PubMed ID: 9171275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intermittent intravenous amrinone infusion: a potentially cost effective mode of treatment of patients with refractory heart failure.
    Levinoff Roth SN; Moe G
    Can J Cardiol; 1993 Apr; 9(3):231-7. PubMed ID: 8508332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.